Skip to main content
. 2020 Dec 3;27(2):236–245. doi: 10.3350/cmh.2020.0204

Figure 3.

Figure 3.

Potential therapeutic options in BCLC stage B. BCLC, Barcelona Clinic Liver Cancer; TACE, transarterial chemoembolization; MTA, molecular targeted agent; ICI, immune checkpoint inhibitor; TARE, transarterial radioembolization.